Montelukast in children with allergic rhinitis amid COVID‐19 pandemic

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalLetter

Abstract

We complement the discussion by Brindisi et al. [1] on the management of allergic rhinitis in children amid novel coronavirus disease 2019 (COVID‐19) pandemic. Brindisi et al. [1] presented a well‐reasoned discussion on the use of intranasal corticosteroids and allergen immunotherapy in children with allergic rhinitis amid COVID‐19 pandemic where they recommend continuation of the former while withholding of the latter upon risk‐benefit assessment.
Original languageEnglish
JournalActa Paediatrica, International Journal of Paediatrics
DOIs
Publication statusE-pub ahead of print - 19 Jul 2020

Fingerprint Dive into the research topics of 'Montelukast in children with allergic rhinitis amid COVID‐19 pandemic'. Together they form a unique fingerprint.

  • Cite this